Efficacy of Probiotics for NSAID-induced Enteropathy in Arthritis Patients - Trial NCT05993247
Access comprehensive clinical trial information for NCT05993247 through Pure Global AI's free database. This Phase 2 trial is sponsored by Jae Myung Park and is currently Not yet recruiting. The study focuses on Osteoarthritis. Target enrollment is 36 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Jae Myung Park
Seoul St. Mary's Hospital
Timeline & Enrollment
Phase 2
Aug 20, 2023
Aug 31, 2025
Primary Outcome
Changes in the small bowel injuries on capsule endoscopy
Summary
This study aimed to investigate the efficacy of probiotics as a preventive agent for
 NSAID-induced enteropathy. Arthritis patients are randomly divided into probiotic and placebo
 groups, and the drug is administered for eight weeks. Before and after drug administration,
 the patient's symptoms/degree of small bowel injuries on capsule endoscopy/microbiome
 composition and diversity were investigated.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05993247
Non-Device Trial